H1N1 News and Research

RSS
Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
Researchers develop a multivalent vaccine for COVID-19 and influenza

Researchers develop a multivalent vaccine for COVID-19 and influenza

Detecting rare blood clots was a win, but US vaccine safety system still has gaps

Detecting rare blood clots was a win, but US vaccine safety system still has gaps

Could CRISPR be used as a SARS-CoV-2 antiviral?

Could CRISPR be used as a SARS-CoV-2 antiviral?

New treatment reduces the severity of ARDS in influenza-infected mice

New treatment reduces the severity of ARDS in influenza-infected mice

Study uncovers a novel autoantigen in patients with narcolepsy type 1

Study uncovers a novel autoantigen in patients with narcolepsy type 1

Study reports on safety of COVID-19 mRNA vaccines in pregnancy

Study reports on safety of COVID-19 mRNA vaccines in pregnancy

Study explores how lessons from past crises could improve the pandemic response

Study explores how lessons from past crises could improve the pandemic response

UGA receives NIH contract to establish the Center for Influenza Disease and Emergence Research

UGA receives NIH contract to establish the Center for Influenza Disease and Emergence Research

Little evidence of COVID-19 vaccine nationalism in public opinion

Little evidence of COVID-19 vaccine nationalism in public opinion

Researchers use South Korea Data to create new framework for COVID-19-vulnerable locales

Researchers use South Korea Data to create new framework for COVID-19-vulnerable locales

Research explores sex differences in placental defenses against SARS-CoV-2 infection

Research explores sex differences in placental defenses against SARS-CoV-2 infection

Research finds key factors that could lead to further pandemics

Research finds key factors that could lead to further pandemics

How one state’s public health defunding led to vaccination chaos

How one state’s public health defunding led to vaccination chaos

Ferret study shows SARS-CoV-2 airborne transmission dynamics

Ferret study shows SARS-CoV-2 airborne transmission dynamics

Vaccine candidate shows promise to protect against dozen-plus flu strains

Vaccine candidate shows promise to protect against dozen-plus flu strains

New computer algorithm offers a path toward pan-influenza and coronavirus vaccine

New computer algorithm offers a path toward pan-influenza and coronavirus vaccine

Graphene oxide-silver nanoparticles shown to rapidly neutralize RNA viruses

Graphene oxide-silver nanoparticles shown to rapidly neutralize RNA viruses

Cellular maps capture COVID-19 pathogenesis in detail

Cellular maps capture COVID-19 pathogenesis in detail

Time to implement measures preventing future viral zoonoses

Time to implement measures preventing future viral zoonoses

Why Astrazeneca and J&J’s vaccines, in use the world over, are still on hold in America

Why Astrazeneca and J&J’s vaccines, in use the world over, are still on hold in America

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.